Bio Medical Life Support Systs is categorized under Kidney Dialysis Centers in Irvington, NJ .
Bio Medical Life Support Systs was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Kidney Dialysis Centers business, which does work in the B2C market, and is classified as a Kidney Dialysis Centers, under code number 6214930 by the NAICS.
If you are seeking more information, feel free to contact Keasha Blake, Manager at the company’s single location by writing to 10 Camptown Road, Irvington, New Jersey NJ 07111 or by phoning (973) 399-1111. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Bio Medical Life Support Systs |
Contact Person: | Keasha Blake, Manager |
Address: | 10 Camptown Road, Irvington, New Jersey 07111 |
Phone Number: | (973) 399-1111 |
Website Address: | fmcna.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Kidney Dialysis Centers |
SIC Code: | 8092 |
NAICS Code: | 6214930 |
Share This Business: |
Bio Medical Life Support Systs was started in 0 to provide professional Kidney Dialysis Centers under the SIC code 8092 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Keasha Blake, Manager for inquiries that concern Bio Medical Life Support Systs by calling the company number (973) 399-1111, as your correspondence is most welcome. Additionally, the physical location of the single location of Bio Medical Life Support Systs can be found at the coordinates 40.72108,-74.24926 as well as the street address 10 Camptown Road in Irvington, New Jersey 07111.
For its online presence, you may visit Bio Medical Life Support Systs’s website at fmcna.com and engage with its social media outlets through on Twitter and on Facebook.